Skip to main content
Clinical Trials/IRCT20090801002266N18
IRCT20090801002266N18RecruitingPhase 3

A comparative study of the effect of a modified method of opioid dependence management with the current method proposed by the Ministry of Health and Medical Education of Iran, on satisfaction, craving and relapse in opioids users.

Esfahan University of Medical Sciences0 sites230 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
230

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20 years to 60 years (—)
Sex
All

Inclusion Criteria

  • Consent to participate in the study
  • Having DSM-5 criteria for drug dependence
  • Regular and daily consumption of opium or heroin orally, injected or smoked
  • Not using other substances
  • Age 20 to 60 years
  • Absence of major psychiatric disorders and absence of physical illness, which is a ban on withdrawing drugs
  • Not taking psychiatric drugs or any drugs that affects the central nervous system

Exclusion Criteria

  • The patient's unwillingness to continue cooperation
  • Occurrence of any medical or ethical conflict with the patient's continued participation in the research
  • Occurrence of physical and mental problems requires special interventions in the process of withdrawing drugs
  • Returning to substance abuse in the treatment process

Investigators

Similar Trials

Comparison of a modified method of opioid... | Clinical Trial